Gastrointestinal toxicities secondary to immune checkpoint inhibitors are very frequent. Because in some instances this can be severe or fatal, it is essential to be able to identify immune-related adverse events rapidly. Prompt initiation of systemic immunosuppression can improve outcomes. A biopsy is often necessary to confirm the diagnosis of immune-related adverse events. Moderate or severe irAEs need an interruption of ICI. After the resolution of the toxicities, the rechallenge of immune checkpoint inhibitors must be discussed case by case.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1024/1661-8157/a003977 | DOI Listing |
Publication Analysis
Top Keywords
gastrointestinal toxicities
8
immune checkpoint
8
checkpoint inhibitors
8
immune-related adverse
8
adverse events
8
immunotherapy gastrointestinal
4
toxicities gastrointestinal
4
toxicities secondary
4
secondary immune
4
inhibitors frequent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!